CME Group (Nasdaq: CME), the world's leading and most diverse derivatives marketplace, today announced that it has received clearance under the Hart-Scott-Rodino Act from the United States Department of Justice - Antitrust Division for its proposed acquisition of NEX Group plc (NXG.L).
CME and NEX have also received the relevant regulatory approvals from the FCA and regulators in the United States, Germany, Italy and Sweden, and have made the requisite pre-notifications in Hong Kong. Completion of the transaction remains subject to satisfaction or waiver of the remaining closing conditions, including competition clearance from the UK Competition and Markets Authority and the sanctioning of the transaction by the U.K. Court. The parties still expect the closing to occur by year end 2018.
